Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1998-8-6
|
| pubmed:abstractText |
Examine the relationship between buprenorphine and norbuprenorphine plasma concentrations with subject-reported withdrawal symptomatology during buprenorphine dose induction, maintenance treatments (daily and alternate-day dosing) and withdrawal.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0965-2140
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
93
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
549-59
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9684393-Administration, Sublingual,
pubmed-meshheading:9684393-Buprenorphine,
pubmed-meshheading:9684393-Heroin Dependence,
pubmed-meshheading:9684393-Humans,
pubmed-meshheading:9684393-Male,
pubmed-meshheading:9684393-Narcotic Antagonists,
pubmed-meshheading:9684393-Substance Withdrawal Syndrome,
pubmed-meshheading:9684393-Time Factors
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
|
| pubmed:affiliation |
Division of Forensic Toxicology, Armed Forces Institute of Pathology, Washington, DC, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|